Tech Times on MSN
Cell therapy maker Pluri takes 50% of ZEO to crack regenerative medicine's $400K cost floor
Regenerative medicine commercialization advanced October 26, 2026, as Pluri Inc. and ZEO ScientifiX announced a 50-50 equity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results